Mikko Niemi

24.1k citations
278 papers · 15.3k · 5 hit papers · h-index 64

Impact in

  • Pharmacology top 0.01%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Oncology top 0.2%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Drug Transport and Resistance Mechanisms 89
    • Pharmacogenetics and Drug Metabolism 66
    • Inflammatory mediators and NSAID effects 12

Mikko Niemi

269 papers receiving 14.8k citations

Mikko Niemi's Hit Papers

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update 2014 · 304 citations
3040+7+15Years since publication200400600

Peers

Mikko Niemi
Comparison fields: 5 of 160
  • Pharmacology 4.7k
  • Oncology 5.4k
  • Pediatrics, Perinatology and Child Health 2.5k
  • Transplantation 242
  • Endocrinology, Diabetes and Metabolism 1.5k
Replace Ivar Roots with:
Ivar Roots Germany
Ulrich M. Zanger Germany
Kathleen M. Giacomini United States
David A. Flockhart United States
Jürgen Brockmöller Germany
Ann K. Daly United Kingdom
Richard B. Kim Canada
Tsuyoshi Yokoi Japan
Erin G. Schuetz United States
Ingolf Cascorbi Germany
Mikko Niemi relative to Ivar Roots Germany Ivar Roots's profile →
Citations per field
00.5×5.0×
Ivar Roots · 1×
Citations per year

Countries citing papers authored by Mikko Niemi

Since Specialization
Citations

This map shows the geographic impact of Mikko Niemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Niemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Niemi more than expected).

Fields of papers citing papers by Mikko Niemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Niemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Niemi. The network helps show where Mikko Niemi may publish in the future.

Co-authors

The 25 scholars most cited alongside Mikko Niemi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mikko Niemi Line = papers co-authored together Mikko Niemi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 278 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Impact of OATP transporters on pharmacokinetics
Hit paper breakdown →
2009744
2
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Hit paper breakdown →
2006638
3
Pharmacokinetic Interactions with Rifampicin
Hit paper breakdown →
2003592
4
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Hit paper breakdown →
2011494
5 2006362
6 2007341
7 2004330
8 2009326
9
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
Hit paper breakdown →
2014304
10 1984287
11 2005287
12 1988269
13 2009249
14 2012243
15 2013209
16 2003206
17 2006199
18 2007196
19 2016191
20 2008177

About Mikko Niemi

Mikko Niemi is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Surgery and Cardiology and Cardiovascular Medicine, having authored 278 papers that have together received 15.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (89 papers), Pharmacogenetics and Drug Metabolism (66 papers), Pharmacological Effects and Toxicity Studies (23 papers), Lipoproteins and Cardiovascular Health (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Sperm and Testicular Function (13 papers), Inflammatory mediators and NSAID effects (12 papers) and HIV/AIDS drug development and treatment (11 papers). The work is most often cited by research in Pharmacology (4.7k citations), Oncology (5.4k citations), Pediatrics, Perinatology and Child Health (2.5k citations), Transplantation (242 citations) and Endocrinology, Diabetes and Metabolism (1.5k citations). Mikko Niemi has collaborated with scholars based in Finland, Germany and United States. Frequent co-authors include Pertti J. Neuvonen, Janne T. Backman, Mikko Neuvonen, Marja K. Pasanen, Annikka Kalliokoski, Kari T. Kivistö, Aleksi Tornio, Martin F. Fromm, M Kotila and Jenni E. Keskitalo. Their work appears in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Basic & Clinical Pharmacology & Toxicology, Pharmacogenetics and Genomics and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact